EUCTR2020-000638-17-NO进行中（未招募）1 期
ZOLEDRONATE EARLY TO HIP FRACTURE PATIENTS– SAFE AND EFFECTIVE?A DOUBLE-BLINDED RANDOMIZED CONTROLLED TREATMENT STRATEGY TRIAL ON ZOLEDRONATE IN HIP FRACTURE PATIENTS THE ZEBRA TRIA
Oslo University Hospital0 个研究点目标入组 300 人开始时间: 2021年1月4日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-Low energy hip fracture
- •-Surgery within 72 hours
- •->50 years old
- •-Acceptable kidney function (eGFR > 35)
- •-Fit to complete the follow-up in the judgement of the recruiting physician
- •-Signed informed consent by patient or next of kin
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 270
排除标准
- •-Metal in the opposite hip
- •-Anti-osteoporotic treatment within the last 10 years
- •-Not fit for treatment with zoledronate in the judgement of the recruiting physician (moribund, too sick)
研究者
相似试验
进行中（未招募）
1 期
Zoledronate Early to Hip Fractures Patients – safe and effective? A Randomized controlled double-blinded treatment strategy trial on Zoledronate in hip fracture patients: The ZEBRA trialHip fractureCTIS2023-510198-32-00Oslo University Hospital HF300
已完成
4 期
Zoledronate Early to Hip Fracture Patients - Safe and Effective?Hip FracturesOsteoporosisNCT05025293Lene Bergendal Solberg228
进行中（未招募）
4 期
Efficacy of Zoledronate in fracture prevention in osteopenic postmenopausal women.ACTRN12609000593235Professor Ian Reid2,000
进行中（未招募）
1 期
Zoledronate against fractures in children with cerebral palsycerebral palsy, osteopenia, fractureMedDRA version: 20.0Level: PTClassification code 10049088Term: OsteopeniaSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 15.1Level: HLTClassification code 10034157Term: Pathological fractures and complicationsSystem Organ Class: 100000005035MedDRA version: 20.0Level: PTClassification code 10049904Term: Osteoporosis prophylaxisSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 20.0Level: LLTClassification code 10021740Term: Infantile cerebral palsySystem Organ Class: 100000012650MedDRA version: 20.0Level: PTClassification code 10006002Term: Bone painSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 20.0Level: LLTClassification code 10013522Term: Disuse osteoporosisSystem Organ Class: 100000018618EUCTR2014-002118-21-DKRanders Regional Hospital
已完成
3 期
Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone MetastasesMetastatic CancerProstate CancerNCT00079001Alliance for Clinical Trials in Oncology645